Clinical TrialID 2543
Phenoxodiol in Treating Patients With Refractory Solid Tumors
NCT00022295
Unspecified Adult Solid Tumor, Protocol Specific
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 2543
- Evidence Id
- 2543
- Core Evidence Id
- 2543
- Source Clinical Trial Id
- 2522
- Herb2 Clinical Trial Id
- HBCT002522
- Nct Id
- NCT00022295
- Title
- Phenoxodiol in Treating Patients With Refractory Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study Result
- No
- Study Condition
- Unspecified Adult Solid Tumor, Protocol Specific
- Study Type
- Interventional
- Study Design
- Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
- Intervention
- DRUG: idronoxil
- Intervention Allocation
- Intervention Model
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 36
- Outcome Measure
- Sponsor Collaborator
- Kazia Therapeutics Limited
- Funded By
- INDUSTRY
- Location
- Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, 44195, United States
- Other Id
- CDR0000068802|NOVOGEN-NV06-0024|CCF-4269|NCI-V01-1663
- Start Date
- 2001-08
- Primary Completion Date
- Completion Date
- 2007-10
- First Posted
- 2003-01-27
- Results First Posted
- Last Update Posted
- 2013-03-26
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00022295
- Title Cn
- Title En
- Phenoxodiol in Treating Patients With Refractory Solid Tumors
- Bilingual Status
- semi_complete